History of primary immunodeficiency diseases in Iran

Iranian Journal of Pediatrics

Volumn 20, Issue 1, 2010, Pages 16-34

  Aghamohammadi, Asghar ^a   Moin, Mostafa ^a,b   Rezaei, Nima ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Primary immunodeficiency diseases; Registries; Research

Indexed keywords

IMMUNOGLOBULIN;

ALLERGY; HEALTH CARE; HEALTH PROGRAM; HISTORY OF MEDICINE; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INFECTION; IRAN; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; REGISTER; REVIEW; TRAINING;

EID: 77749314940     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Bonilla FA, Geha RS. Primary immunodeficiency diseases. J Allergy Clin Immunol. 2003;111(2 Suppl):S571-81.
2. Geha RS, Notarangelo LD, Casanova JL, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120(4):776-94.
3. Rezaei N, Aghamohammadi A, Notarangelo LD. Primary immunodeficiency diseases: definition, diagnosis and management. Berlin Heidelberg:Springer;2008.
4. Notarangelo LD, Fischer A, Geha RS, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124(6):1161-78.
5. Primary Immunodeficiency Expert Committee. Available at: http://www.iuisonline.org/pages/primimmun.htm. Access date: Dec 2009.
6. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497-502.
7. Champi C. Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment. J Pediatr Health Care. 2002;16(1):16-21.
8. Woroniecka M, Ballow M. Office evaluation of children with recurrent infection. Pediatr Clin North Am. 2000;47(6):1211-24.
9. Tadjbakhsh H. The life of Muhammad lbn Zakariya Razi and the discovery of allergic asthma. Iran J Allergy Asthma Immunol. 2000;1(1):3-9.
10. Behbehani AM. The smallpox story: life and death of an old disease. Microbiol Rev. 1983;47(4):455-509.
11. Wilkinson L. The development of the virus concept as reflected in corpora of studies on individual pathogens. 5. Smallpox and the evolution of ideas on acute (viral) infections. Med Hist. 1979;23(1):1-28.
12. Bungy GA, Mossawi J, Nojoumi SA, et al. Razi's report about seasonal allergic rhinitis (hay fever) from the 10th century AD. Int Arch Allergy Immunol. 1996;110(3):219-24.
13. Tauber AI, Chernyak L. The birth of immunology. II. Metchnikoff and his critics. Cell Immunol. 1989;121(2):447-73.
14. von Behring E, Kitasato S. (The mechanism of diphtheria immunity and tetanus immunity in animals. 1890). Mol Immunol. 1991;28(12):1317,9-20.
15. Moore HD. Complementary and opsonic functions in their relation to immunity. A study of the serum of guinea pigs naturally deficient in complement. J Immunol. 1919;4:425-41.
16. Schultz W. Ueber eigenartige Hals erkrankungen. Dtsch Med Wochenschr. 1922;48:1495-7.
17. Syllaba L, Henner K. Contribution a l'independence de l'athetose double idiopathique et congenitale: atteinte familiale, syndrome dystrophique, signe du reseau vasculaire conjonctival, integrite psychique. Rev Neurol (Paris). 1926;1:541-62.
18. Thorpe ES, Handley HE. Chronic tetany and chronic mycelial stomatitis in a child aged four and one half years. Am J Dis Child 1929;38:328-38.
19. Wiskott A. Familiarer angeborener Morbus Werlhofii? Arch Kinderheilk. 1937;68:212-16.
20. Bruton OC. Agammaglobulinemia. Pediatrics 9:1952;9:722-8.
21. Rezaei N. Obituary: Abolhassan Farhoudi (1924-2006). Iran J Allergy Asthma Immunol. 2006;5(1):1.
22. Farhoudi A. Cell mediated immunodeficiency after BCG vaccination. Dev Biol Stand. 1986;58 (Pt A):347-9.
23. Farhoudi AH. (Recurrent pneumococcal meningitis associated with C3 deficiency). Presse Med. 1988;17(14):696.
24. Warner JO, Kaliner MA, Crisci CD, et al. Allergy practice worldwide:a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol. 2006;139(2):166-74.
25. Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117(4 Suppl):S525-53.
26. Aghamohammadi A, Moin M, Farhoudi A, et al. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol Med Microbiol. 2004;40(2):113-8.
27. Pourpak Z, Aghamohammadi A, Sedighipour L, et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect. 2006;39(2):114-20.
28. Atarod L, Aghamohammadi A, Moin M, et al. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy. Iran J Allergy Asthma Immunol. 2007;6(1):37-40.
29. Aghamohammadi A, Farhoudi A, Nikzad M, et al. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann Allergy Asthma Immunol. 2004;92(1):60-4.
30. Dashti Khavidaki S, Aghamohammadi A, Farshadi F, et al. Adverse reactions of prophylactic intravenous immunoglobulin; a 13 year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Investig Allergol Clin Immunol. 2009;19(2):139-45.
31. Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J Clin Immunol. 2005;25(1):73-7.
32. Al Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004-2006). J Clin Immunol. 2008;28(2):186-93.
33. Iwata C, Hayakawa H. (Registry of cases with primary immunodeficiency syndrome in Japan). Nihon Rinsho Meneki Gakkai Kaishi. 2002;25(4):289-301.
34. Leiva LE, Zelazco M, Oleastro M, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27(1):101-8.
35. Luzi G, Businco L, Aiuti F. A national registry for primary immunodeficiency syndromes in Italy: a report for the period 1972 1982. Birth Defects Orig Artic Ser. 1983;19(3):161-3.
36. Matamoros Flori N, Mila Llambi J, Espanol Boren T, et al. Primary immunodeficiency syndrome in Spain:first report of the National Registry in Children and Adults. J Clin Immunol. 1997;17(4):333-9.
37. Fasth A. Primary immunodeficiency disorders in Sweden: cases among children, 1974 1979. J Clin Immunol. 1982;2(2):86-92.
38. Affentranger P, Morell A, Spath P, et al. Registry of primary immunodeficiencies in Switzerland. Immunodeficiency. 1993;4(1 4):193-5.
39. Baumgart KW, Britton WJ, Kemp A, et al. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol. 1997;100(3):415-23.
40. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27(5):517-24.
41. Farhoudi A, Aghamohammadi A, Moin M, et al. Distribution of primary immunodeficiency disorders diagnosed in the Children's Medical Center in Iran. J Investig Allergol Clin Immunol. 2005;15(3):177-82.
42. Rezaei N, Aghamohammadi A, Moin M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran:update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26(6):519-32.
43. Aghamohammadi A, Moein M, Farhoudi A, et al. Primary immunodeficiency in Iran:first report of the National Registry of PID in Children and Adults. J Clin Immunol. 2002;22(6):375-80.
44. Rezaei N, Pourpak Z, Aghamohammadi A, et al. Consanguinity in primary immunodeficiency disorders;the report from Iranian Primary Immunodeficiency Registry. Am J Reprod Immunol. 2006;56(2):145-51.
45. Mansouri D, Adimi P, Mirsaedi M, et al. Primary immune deficiencies presenting in adults: seven years of experience from Iran. J Clin Immunol. 2005;25(4):385-91.
46. Aghamohammadi A, Farhoudi A, Moin M, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol. 2005;12(7):825-32.
47. Moin M, Aghamohammadi A, Farhoudi A, et al. X linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol Invest. 2004;33(1):81-93.
48. Aghamohammadi A, Cheraghi T, Gharagozlou M, et al. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol. 2009;29(1):130-6.
49. Yeganeh M, Heidarzade M, Pourpak Z, et al. Severe combined immunodeficiency: a cohort of 40 patients. Pediatr Allergy Immunol. 2008;19(4):303-6.
50. Moin M, Aghamohammadi A, Kouhi A, et al. Ataxia telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007;37(1):21-8.
51. Fazlollahi MR, Farhoudi A, Movahedi M, et al. Chronic mucocutaneous candidiasis; report of three cases with different phenotypes. Iran J Allergy Asthma Immunol. 2005;4(1):39-42.
52. Rezaei N, Farhoudi A, Ramyar A, et al. Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol. 2005;27(7):351-6.
53. Rezaei N, Farhoudi A, Pourpak Z, et al. Clinical and laboratory findings in Iranian children with cyclic neutropenia. Iran J Allergy Asthma Immunol. 2004;3(1):37-40.
54. Movahedi M, Aghamohammadi A, Rezaei N, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int Arch Allergy Immunol. 2004;134(3):253-9.
55. Moin M, Farhoudi A, Movahedi M, et al. The clinical and laboratory survey of Iranian patients with hyper IgE syndrome. Scand J Infect Dis. 2006;38(10):898-903.
56. Movahedi M, Entezari N, Pourpak Z, et al. Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases). J Clin Immunol. 2007;27(3):302-7.
57. Farhoudi A, Chavoshzadeh Z, Pourpak Z, et al. Report of six cases of Chediak Higashi syndrome with regard to clinical and laboratory findings. Iran J Allergy Asthma Immunol. 2003;2(4):189-92.
58. Aghamohammadi A, Fiorini M, Moin M, et al. Clinical, immunological and molecular characteristics of 37 Iranian patients with X linked agammaglobulinemia. Int Arch Allergy Immunol. 2006;141(4):408-14.
59. Aghamohammadi A, Parvaneh N, Kanegana H, et al. Screening of the Bruton tyrosine kinase (BTK) gene mutations in 13 Iranian patients with presumed X linked Agammaglobulinemia. Iran J Allergy Asthma Immunol. 2004;3(4):175-9.
60. Aghamohammadi A, Parvaneh N, Rezaei N, et al. Clinical and laboratory findings in Hyper IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009;29(6):769-76.
61. Mamishi S, Modarressi MH, Pourakbari B, et al. Analysis of RAB27A gene in Griscelli syndrome type 2: novel mutations including a deletion hotspot. J Clin Immunol. 2008;28(4):384-9.
62. Teimourian S, Rezvani Z, Badalzadeh M, et al. Molecular diagnosis of X linked chronic granulomatous disease in Iran. Int J Hematol. 2008;87(4):398-404.
63. Teimourian S, Zomorodian E, Badalzadeh M, et al. Characterization of six novel mutations in CYBA:the gene causing autosomal recessive chronic granulomatous disease. Br J Haematol. 2008;141(6):848-51.
64. Rezaei N, Moin M, Pourpak Z, et al. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J Clin Immunol. 2007;27(5):525-33.
65. Aghamohammadi A, Cheraghi T, Rezaei N, et al. Neutropenia associated with X linked agammaglobulinemia in an Iranian referral center. Iran J Allergy Asthma Immunol. 2009;8(1):43-7.
66. Fahimzad A, Chavoshzadeh Z, Abdollahpour H, et al. Necrosis of nasal cartilage due to mucormycosis in a patient with severe congenital neutropenia due to HAX1 deficiency. J Investig Allergol Clin Immunol. 2008;18(6) 469-72.
67. Khalilzadeh S, Bloorsaz MR, Mansouri D, et al. Clinical and radiological aspects of chronic granulomatous disease in children: a case series from Iran. Iran J Allergy Asthma Immunol. 2006;5(2):85-8.
68. Mansouri D, Adimi P, Mirsaeidi M, et al. Inherited disorders of the IL 12 IFN gamma axis in patients with disseminated BCG infection. Eur J Pediatr. 2005;164(12):753-7.
69. Rezaei N, Aghamohammadi A, Ramyar A, et al. Severe congenital neutropenia or hyper IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia. Int Arch Allergy Immunol. 2008;147(3):255-9.
70. Rezaei N, Chavoshzadeh Z, O RA, et al. Association of HAX1 deficiency with neurological disorder. Neuropediatrics. 2007;38(5):261-3.
71. Sadeghi Shabestari M, Rezaei N. Disseminated bacille Calmette Guerin in Iranian children with severe combined immunodeficiency. Int J Infect Dis. 2009;13(6):e420-3.
72. Sadeghi Shabestari M, Vesal S, Jabbarpour Bonyadi M, et al. Novel RAG2 mutation in a patient with T-, B-, severe combined immunodeficiency and disseminated BCG disease. J Investig Allergol Clin Immunol. 2009;19(6):494-6.
73. Safari M, Rezaei N, Hajilooi M, et al. Onychomadesis in a patient with immunoglobulin class switch recombination deficiency. Iran J Allergy Asthma Immunol. 2008;7(1):41-4.
74. Salipante SJ, Benson KF, Luty J, et al. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat. 2007;28(9):874-81.
75. Shamsian BS, Mansouri D, Pourpak Z, et al. Autosomal recessive chronic granulomatous disease, IgA deficiency and refractory autoimmune thrombocytopenia responding to Anti CD20 monoclonal antibody. Iran J Allergy Asthma Immunol. 2008;7(3):181-4.
76. Tabarsi P, Mirsaeidi M, Karimi S, et al. Lymphocytic bronchiolitis as presenting disorder in an undiagnosed adult patient with chronic granulomatous disease. Iran J Allergy Asthma Immunol. 2007;6(4):219-21.
77. Tabatabaie P, Mahjoub F, Cheraghi T, et al. Griscelli syndrome type 2; a pediatric case with immunodeficiency. Iran J Allergy Asthma Immunol. 2007;6(3):155-7.
78. Tafti SF, Tabarsi P, Mansouri N, et al. Chronic granulomatous disease with unusual clinical manifestation, outcome, and pattern of inheritance in an Iranian family. J Clin Immunol. 2006;26(3):291-6.
79. Shabestari MS, Maljaei SH, Baradaran R, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007;27(5):510-6.
80. Shabestari MS, Rezaei N. Asthma and allergic rhinitis in a patient with BTK deficiency. J Investig Allergol Clin Immunol. 2008;18(4):300-4.
81. Mamishi S, Esfahani SA, Parvaneh N, et al. Severe congenital neutropenia in 2 siblings of consanguineous parents. The role of HAX1 deficiency. J Investig Allergol Clin Immunol. 2009;19(6):500-3.
82. Aghamohammadi A, Kanegane H, Moein M, et al. Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency. Int J Hematol. 2003;78(1):45-7.
83. Farhoudi A, Bazargan N, Pourpak Z, et al. Two related cases of primary complement deficiency. Immunol Invest. 2003;32(4):313-21.
84. Shahmahmoodi S, Parvaneh N, Burns C, et al. Isolation of a type 3 vaccine derived poliovirus (VDPV) from an Iranian child with X linked agammaglobulinemia. Virus Res. 2008;137(1):168-72.
85. Mamishi S, Parvaneh N, Salavati A, et al. Invasive aspergillosis in chronic granulomatous disease: report of 7 cases. Eur J Pediatr. 2007;166(1):83-4.
86. Mamishi S, Shahmahmoudi S, Tabatabaie H, et al. Novel BTK mutation presenting with vaccine associated paralytic poliomyelitis. Eur J Pediatr. 2008;167(11):1335-8.
87. Parvaneh N, Shahmahmoudi S, Tabatabai H, et al. Vaccine associated paralytic poliomyelitis in a patient with MHC class II deficiency. J Clin Virol. 2007;39(2):145-8.
88. Parvaneh N, Teimourian S, Jacomelli G, et al. Novel mutations of NP in two patients with purine nucleoside phosphorylase deficiency. Clin Biochem. 2008;41(4 5):350-2.
89. Alborzi A, Hosseini nasab A, Zeyaeian M, et al. A case of hypogammaglobulinemia with enteroviral meningoencephalitis, associated with increased adenosine deaminase in cerebrospinal fluid. Iran J Allergy Asthma Immunol. 2009;8(2):117-9.
90. Kashef MA, Kashef S, Handjani F, et al. Hodgkin lymphoma developing in a 4.5 year old girl with hyper IgE syndrome. Pediatr Hematol Oncol. 2006;23(1):59-63.
91. Gharagozlou M, Ebrahimi FA, Farhoudi A, et al. Pulmonary complications in primary hypogammaglobulinemia:a survey by high resolution CT scan. Monaldi Arch Chest Dis. 2006;65(2):69-74.
92. Khodadad A, Aghamohammadi A, Parvaneh N, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci. 2007;52(11):2977-83.
93. Atarod L, Raissi A, Aghamohammadi A, et al. A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10 year period (1990 2000), in Children Hospital Medical Center. Iran J Allergy Asthma Immunol. 2003;2(2):75-9.
94. Aghamohammadi A, Pouladi N, Parvaneh N, et al. Mortality and morbidity in common variable immunodeficiency. J Trop Pediatr. 2007;53(1):32-8.
95. Ramyar A, Aghamohammadi A, Moazzami K, et al. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2008;7(3):169-75.
96. Aghamohammadi A, Parvaneh N, Tirgari F, et al. Lymphoma of mucosa associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma. 2006;47(2):343-6.
97. Aghamohammadi A, Rezaei N, Gharagozlou M, et al. Hodgkin lymphoma in two siblings with common variable immunodeficiency. Pediatr Hematol Oncol. 2007;24(5):337-42.
98. Nourizadeh M, Aghamohammadi A, Moazzeni SM, et al. Altered dendritic cell function in response to sera of common variable immunodeficiency patients. Inflamm Res. 2007;56(12):527-32.
99. Nourizadeh M, Aghamohammadi A, Moazzeni SM, et al. High production of IL 18 by dendritic cells induced by sera from patients with primary antibody deficiency. Iran J Allergy Asthma Immunol. 2007;6(2):59-65.
100. Ravanbakhsh M, Sarafnejad A, Aghamohammadi A, et al. CD40 ligand expression on stimulated T helper lymphocytes in patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2007;6(3):129-35.
101. Rezaei N, Aghamohammadi A, Kardar GA, et al. T helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2008;18(6):449-53.
102. Rezaei N, Haji Molla Hoseini M, Aghamohammadi A, et al. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J Clin Immunol. 2008;28(1):78-84.
103. Vodjgani M, Aghamohammadi A, Samadi M, et al. Analysis of class switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol. 2007;17(5):321-8.
104. Rezaei N, Aghamohammadi A, Read RC. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease. Iran J Allergy Asthma Immunol. 2008;7(4):231-4.
105. Aghamohammadi A, Foroughi F, Rezaei N, et al. Mannose binding lectin polymorphisms in common variable immunodeficiency. Clin Exp Med. 2009;9(4):285-90.
106. Rezaei N, Aghamohammadi A, Mahmoudi M, et al. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency. Immunobiology. 2009.
107. Rezaei N, Aghamohammadi A, Shakiba Y, et al. Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol. 2009;150(1):1-7.
108. Rezaei N, Amirzargar AA, Shakiba Y, et al. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol. 2009;155(1):21-7.
109. Aghamohammadi A, Moin M, Kouhi A, et al. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology. 2008;213(5):447-54.
110. Aghamohammadi A, Parvaneh N, Rezaei N. Common variable immunodeficiency: a heterogeneous group needs further subclassification. Expert Rev Clin Immunol. 2009;5(6):629-31.
111. Mohammadi J, Liu C, Aghamohammadi A, et al. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol. 2009;29(6):777-85.
112. Aghamohammadi A, Moazzami K, Rezaei N, et al. ENT manifestations in Iranian patients with primary antibody deficiencies. J Laryngol Otol. 2008;122(4): 409-13.
113. Motamed F, Aghamohammadi A, Soltani M, et al. Evaluation of liver diseases in Iranian patients with primary antibody deficiencies. Ann Hepatol. 2009;8(3):196-202.
114. Fazlollahi MR, Aghamohammadi A, Hosseini RF, et al. Study of alpha1 antitrypsin phenotypes frequencies in patients with primary antibody deficiency. Iran J Allergy Asthma Immunol. 2006;5(2):69-74.
115. Zeinaloo AA, Aghamohammadi A, Shabanian R, et al. Echocardiographic abnormalities and their correlation with bronchiectasis score in primary antibody deficiencies. J Cardiovasc Med (Hagerstown). 2009: in press.
116. Aghamohammadi A, Moin M, Karimi A, et al. Immunologic evaluation of patients with recurrent ear, nose, and throat infections. Am J Otolaryngol. 2008;29(6):385-92.
117. Tabatabaie P, Aghamohammadi A, Mamishi S, et al. Evaluation of humoral immune function in patients with bronchiectasis. Iran J Allergy Asthma Immunol. 2008;7(2):69-77.
118. Aghamohammadi A, Mohammadi J, Parvaneh N, et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol. 2008;147(2):87-92.
119. Rezaei N, Aghamohammadi A, Siadat SD, et al. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol. 2008;15(4):607-11.
120. Rezaei N, Aghamohammadi A, Siadat SD, et al. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine. 2007;25(29):5308-14.
121. Isaian A, Bogdanova NV, Houshmand M, et al. BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with Ataxia Telangiectasia. J Clin Immunol. 2009.
122. Rezaei N. TNF receptor associated periodic syndrome (TRAPS):an autosomal dominant multisystem disorder. Clin Rheumatol. 2006;25(6):773-7.
123. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39(1):86-92.
124. Boztug K, Appaswamy G, Ashikov A, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med. 2009;360(1):32-43.
125. Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med. 2009;361(18):1727-35.
126. Yeganeh M, Henneke P, Rezaei N, et al. Toll like receptor stimulation induces higher TNF alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndrome. Int Arch Allergy Immunol. 2008;146(3):190-4.
127. Germeshausen M, Grudzien M, Zeidler C, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform dependent genotype phenotype associations. Blood. 2008;111(10):4954-7.
128. Engelhardt KR, McGhee S, Winkler S, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal recessive form of hyper IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289-302 e4.
129. Vogt G, Chapgier A, Yang K, et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet. 2005;37(7):692-700.
130. Mohammadi J, Ramanujam R, Jarefors S, et al. IgA deficiency and the MHC: Assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J Clin Immunol. 2010;30(1):138-43.
131. Kashef S, Ghaedian MM, Rezaei N, et al. Isolated growth hormone deficiency in a patient with immunoglobulin class switch recombination deficiency. J Investig Allergol Clin Immunol. 2009;19(3):233-6.
132. Rezaei N, Farhoudi A, Pourpak Z, et al. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica. 2005;90(4):554-6.
133. Carlsson G, van't Hooft I, Melin M, et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med. 2008;264(4):388-400.
134. Ishikawa N, Okada S, Miki M, et al. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet. 2008;45(12):802-7.
135. Matsubara K, Imai K, Okada S, et al. Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency. Haematologica. 2007;92(12):e123-5.
136. Rezaei N, Moazzami K, Aghamohammadi A, et al. Neutropenia and primary immunodeficiency diseases. Int Rev Immunol. 2009;28(5):335-66.
137. Moin M, Mahmoudi M, Rezaei N. Scientific output of Iran at the threshold of the 21st century. Scientometrics. 2005;62(2):239-48.
138. Gennery A. Book review: Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management. Immunology News, British Society of Immunology. 2009:46.
139. Webster ADB. Book review: Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management. JAMA. 2009;302(9):1006-7.
140. Isaian A, Moin M, Pourpak Z, et al. DNA banking of primary immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol. 2006;5(4):201-2.
141. Azari S, Ahmadi N, Tehrani MJ, et al. Profiling and authentication of human cell lines using short tandem repeat (STR) loci: Report from the National Cell Bank of Iran. Biologicals. 2007;35(3):195-202.
142. Hamidieh AA, Pourpak Z, Alimoghaddam K, et al. Successful allogeneic stem cell transplantation with a reduced intensity conditioning in a leukocyte adhesion deficiency type I patient. Pediatr Transplant. 2009: in press.
143. Ghavamzadeh A, Alimoghaddam K, Jahani M, et al. Stem cell transplantation; Iranian experience. Arch Iran Med. 2009;12(1):69-72.
144. Rahiminejad MS, Kashef S. Posttransfusion graft versus host disease in an infant with severe combined immunodeficiency. Transplant Proc. 2003;35(7):2825-6.